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As metástases nas leptomeninges da espinal medula 
ocorrem raramente nos tumores sólidos e o prognóstico 
é bastante reservado. Os adenocarcinomas e os carcino-
mas de pequenas células são os grupos histológicos mais 
envolvidos no que se refere aos tumores pulmonares. 
Um homem de 58 anos com história de carcinoma de 
células escamosas do pulmão com inversão mediastínica 
e metástases cerebrais apresenta lombalgias e fraqueza 
em ambos os membros inferiores. A RMN da coluna 
vertebral revelou espessamento na espinal medula e múl-
tiplos nódulos do grupo das fibras da cauda equina. Tan-
to quanto sabemos, trata-se do segundo caso relatado de 
carcinoma pulmonar de células escamosas que apresenta 
metástases nas leptomeninges da espinal medula.
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Abstract
Spinal leptomeningeal metastasis occurs rarely in solid 
tumors, and the prognosis is extremely poor. Adenocar-
cinomas and small-cell carcinomas are the most com-
mon histological type detected among lung tumors. A 
58-year-old man with a history of squamous-cell lung 
carcinoma with mediastinal invasion and brain metasta-
sis was examined because of his low back pain and weak-
ness in both lower limbs. Spinal MRI revealed subpial 
enhancement in the spinal cord; and innumerable no-
dules with thickening of the cauda equina fibres. To our 
knowledge, this is the second reported case of squamous 
cell lung cancer with spinal leptomeningeal metastasis.
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Introduction
Leptomeningeal metastases are being recog-
nized with increasing frequency in last de-
cades as the result of improved therapy of 
systemic malignancies. Increased the life 
span of cancer patients allow the late expres-
sion of leptomeningeal metastases. Advan-
ces in technology increase the sensitivity of 
neuroradiological imaging enables to diag-
nose the leptomeningeal metastases1-4. Ano-
ther reason is that the meninges are a sanc-
tuary for many cytotoxic agents that have 
difficulty crossing the intact blood-CSF 
barrier, therefore tumor cells in the suba-
rachnoid tumor are not adequately treated 
and may proliferate4. Finally infiltration of 
the leptomeninges by any malignancy is a 
serious complication that results in substan-
tial morbidity and mortality2.
In the present report we describe a patient 
with squamous cell lung cancer, who deve-
loped a leptomeningeal infiltration in cauda 
equina fibers and spinal cord.
Case report
A 58 years-old male patient was evaluated 
for his treatment management with the dia-
gnosis of low-differentiated squamous cell 
lung cancer in our clinic in february 2007. 
He had a mass in the right lung with me-
diastinal invasion and multiple mediastinal 
lymphadenopathies in the right inferior 
paratracheal region. But no other metasta-
ses had been detected on abdominal com-
puted tomography (CT), cranial magnetic 
resonance imaging (MRI), whole body po-
sitron emission tomography and skeletal 
surveys. With the diagnosis of a locally ad-
vanced NSCLC he had an induction 
chemotherapy with cisplatin (75mg/m2) 
and docetaxel (75mg/m2). After three cycles 
of combination chemotherapy, a total dose 
of 64Gy in 32 fractions external adjuvant 
radiotherapy to the right lung and mediasti-
num was performed combined with two 
cycles of cisplatin (60mg/m2). Following 
chemoradiotherapy, thorax CT revealed, 
minimal regression in the mass and me-
diastinal lymph nodes. Five months later he 
presented with vertigo complaints, cranial 
MRI revealed multiple metastatic nodules 
with mass effect in the right superior tem-
poral gyrus, left frontopatietal, frontal and 
parietal lobes. There was not leptomenin-
geal enhancement. 30 Gy in 10 fractions 
palliative whole-brain RT was performed 
for his brain metastases. After one month, 
he had low back pain referring to both legs, 
and weakness in his legs complaints. A spi-
nal MRI was performed to exclude bone 
metastasis. Innumerable small hypointense 
nodules were detected along the cauda equi-
na fibers on T2 weighted sagittal scan 
(Fig. 1A). After the administration of gado-
linium chelate, diffuse innumerable nodular 
enhancement and thickening in the nerve 
fibers was seen. Small subpial metastatic 
nodules were also detected in the lower me-
dulla spinalis (Figs. 1B and 2). 17,5 Gy in 5 
fractions external palliative radiotherapy 
was performed to T2-T12 and L1-S2 spinal 
areas using a posterior field. Unfortunately 
he died in January 2008.
Discussion
Primary CNS malignancies especially 
medulloblastoma and CNS lymphoma are 
the most common cause of leptomeningeal 
metastases. Cancers such as leukemia, lym-
phoma, breast cancer, lung cancer, and mela-
Metástases nas leptomeninges da espinal medula num doente com carcinoma 
de céculas escamosas do pulmão
Banu Alicioglu, Mert Saynak
R e v i s t a  P o r t u g u e s a  d e  P n e u m o l o g i a 877
Vol XIV  N.º 6  Novembro/Dezembro  2008
noma frequently involve the leptomeninges2. 
Although the availability of new diagnostic 
modalities, leptomeningeal carcinomatosis 
remains underdiagnosed and underestima-
ted. Additionally, patients already diagnosed 
with brain metastais, symptoms and signs re-
lating to the brain were attributed to these 
cerebral metastases3. Therefore the incidence 
varies between different studies. Approxi-
mately, 9-25% of patients with lung cancer, 
2-15% of all patients with breast cancer and 
15-25% of patients with melanoma will de-
velop leptomeningeal metastases1,5.
Adenocarcinoma and small cell carcinoma 
of the lung are frequently seen with lepto-
meningeal carcinomatosis1,2,5,6. Leptomenin-
geal metastasis of squamous cell lung cancer 
is extremely rare. As far as we are aware, 
only one case is reported7 except ours.
The tumor cells could reach the leptome-
ninges by several mechanisms: Arterial route 
(in patients with disseminated cancer, the 
leptomeninges are infiltrated through arach-
noid vessels or choroid plexus); direct ex-
tension of the leptomeninges or seeding 
(primary CNS tumors), growing around 
and along peripheral nerves to the subarach-
noid space (systemic tumors), iatrogenic 
(seeding of subarachnoid space during sur-
gical extirpation of intraparenchymal me-
tastases), entry to the subarachnoid space 
through the venous plexus of Batson and 
perivenous spread from adjacent bone mar-
row metastases. In most cases of breast or 
lung cancer pure leptomeningeal carcino-
matosis is the result of cancer propagation 
from vertebral or paravertebral metasta-
ses1-4,9. New metastatic deposits along me-
ningeal surfaces which invade subpial pa-
renchyma, penetrate spinal nerve roots, and 
produce masses in the subarachnoid space. 
Fig. 1 – Sagittal T2-weighted (A) MRI scan shows small 
hypointense nodules in the cauda equina fi bers. After the 
injection of the gadolinium, T1-weighted scan (B) shows 
extensive leptomeningeal metastases in the cauda equina. 
No vertebral metastasis was seen
Fig. 2 – Transverse T1-weighted gadolinium-enhanced MRI 
scan at the L1-2 level. Enhancement of the cauda equina 
fi bers in the thecal sac is seen
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The most frequently affected regions of the 
CNS are the basilar cisterns, the posterior 
fossa, and the cauda equina where slow CSF 
flow and gravity promote the deposition of 
circulating cells1.
Most patients with leptomeningeal metasta-
ses have widely disseminated cancer, As sys-
temic therapy improves, progression of di-
sease within the central nervous system 
becomes an increasing problem. 33-75% of 
patients with neoplastic meningitis had syn-
chronous intraparenchymal brain metasta-
ses1,2. The clinical presentation of leptome-
ningeal metastases usually involves spinal 
cord symptoms that attributed to radicu-
lopathy at the involved level, lumbosacral 
region which is particularly common. Pa-
ralysis and vesicorectal disturbance may re-
sult from intracranial lesions, and thus it is 
often difficult to distinguish between the 
conditions of spinal origin and those of in-
tracranial origin. However, clinical signs 
and symptoms of leptomeningeal metasta-
ses may be absent or may underestimate the 
extent of macroscopic disease1,2,9.
Gadolinim-enhanced MRI is the standart 
and most sensitive radiological technique 
when leptomeningeal metastasis is suspec-
ted4,10. The entire imaging of the neuraxis is 
mandatory because up to 50% of patients 
have multi-level disease, which has a poorer 
prognosis than single site involvement5,10. The 
imaging features of spinal leptomeningeal 
metastasis on MRI are: Intradural enhancing 
nodules in spinal canal, spinal linear enhance-
ment, Spinal cord enlargement and the asym-
metry of the roots4,7,12. High-signal metastatic 
lesions on T2 imaging may contrast poorly 
with similarly intense marrow fat, and this se-
quence should not be exclusively relied on for 
lesion detection10. In the contrary the metas-
tatic nodules of our patient were visible on 
unenhanced MR scans, they were hypoin-
tense on T2-weighted images which is boun-
ded to the high mitotic activity in the masses.
Diagnostic imaging together with CSF cy-
tology provides useful information, but re-
peated examinations may be necessary to 
establish the diagnosis. A raised cell count, 
increased protein levels, increased levels of 
lactate dehydrogenase in the CSF when 
compared with serum levels are all sug ges-
tive of leptomeningeal disease, even when 
cytology is negative. It is important to per-
form MRI before CSF examination to avoid 
lumbar puncture-induced gadolinium en-
hancement of the arachnoid, which may 
last for weeks to months. This enhancement 
can easily be mistaken for leptom eningeal 
disease4,5.
The treatment of leptomeningeal metastasis 
is palliative because eradication of tumor 
from the subarachnoid space with existing 
therapy is extremely rare1,10 The metastasis 
of systemic cancers usually occurs in the ter-
minal phase of illness. The median survival 
among patients with leptomeningeal metas-
tasis located in the spinal cord was 2.4 
months13. The goals of treatment in patients 
with leptomeningeal metastases are to relieve 
symptoms, improve or stabilize the neuro-
logic status of the patient, and prolong sur-
vival1,2. Despite these measures the prognosis 
is poor, with a median survival of 2-3 
months, and focal neurologic dysfunctions 
do not improve in most cases. Treatment is 
usually with external beam radiotherapy, 
systemic chemotherapy, and intrathecal che-
motherapy with methotrexate, thiotepa, and 
cytarabine13. Although surgery is indicated 
in neurological deficit, spinal instability and 
radiation treatment failure10,13.
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As a conclusion, spinal leptomeningeal me-
tastasis is extremely rarely seen in squamous-
cell lung cancer. Contrast-enhanced MR 
imaging is useful in the diagnosis of pial 
spread of metastatic disease in patients with 
a known primary malignancy and unex-
plained neurologic signs or symptoms.
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